FastBack Bio
Cambridge, United States· Est. 2021
FastBack Bio develops novel gene therapy delivery technologies for treating genetic diseases.
Private Company
Total funding raised: $8M
About
FastBack Bio develops novel gene therapy delivery technologies for treating genetic diseases.
Cell & Gene Therapy
Funding History
1Total raised:$8M
Seed$8MSep 15, 2021